loadpatents
name:-0.052976131439209
name:-0.03252387046814
name:-0.013020992279053
Wustrow; David Juergen Patent Filings

Wustrow; David Juergen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wustrow; David Juergen.The latest application filed is for "ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereof".

Company Profile
12.30.46
  • Wustrow; David Juergen - Los Gatos CA
  • Wustrow; David Juergen - Ann Arbor MI
  • Wustrow; David Juergen - Madison CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Chemokine receptor modulators and uses thereof
Grant 11,384,064 - Jackson , et al. July 12, 2
2022-07-12
Chemokine receptor modulators and uses thereof
Grant 11,192,879 - Jackson , et al. December 7, 2
2021-12-07
Ubiquitin-specific-processing Protease 7 (usp7) Modulators And Uses Thereof
App 20210317134 - Schwarz; Jacob Bradley ;   et al.
2021-10-14
Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
Grant 11,084,829 - Biannic , et al. August 10, 2
2021-08-10
Chemokine Receptor Modulators And Uses Thereof
App 20200339539 - Jackson; Jeffrey J. ;   et al.
2020-10-29
Chemokine Receptor Modulators And Uses Thereof
App 20200325117 - Jackson; Jeffrey J. ;   et al.
2020-10-15
Chemokine Receptor Modulators And Uses Thereof
App 20200239480 - Beck; Hilary Plake ;   et al.
2020-07-30
Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
Grant 10,722,514 - Biannic , et al.
2020-07-28
Chemokine receptor modulators and uses thereof
Grant 10,683,280 - Jackson , et al.
2020-06-16
Chemokine receptor modulators and uses thereof
Grant 10,604,526 - Beck , et al.
2020-03-31
Ubiquitin-specific-processing Protease 7 (usp7) Modulators And Uses Thereof
App 20200095260 - Biannic; Berenger ;   et al.
2020-03-26
Chemokine Receptor Modulators And Uses Thereof
App 20190233397 - Jackson; Jeffrey J. ;   et al.
2019-08-01
Chemokine Receptor Modulators And Uses Thereof
App 20190152978 - Beck; Hilary Plake ;   et al.
2019-05-23
Ubiquitin-specific-processing Protease 7 (usp7) Modulators And Uses Thereof
App 20190142834 - Biannic; Berenger ;   et al.
2019-05-16
Chemokine receptor modulators and uses thereof
Grant 10,246,462 - Beck , et al.
2019-04-02
Chemokine receptor modulators and uses thereof
Grant 10,179,787 - Beck , et al. Ja
2019-01-15
Chemokine Receptor Modulators And Uses Thereof
App 20180072740 - Beck; Hilary Plake ;   et al.
2018-03-15
Chemokine Receptor Modulators And Uses Thereof
App 20180072743 - Beck; Hilary Plake ;   et al.
2018-03-15
Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH
App 20110039899 - Taylor, JR.; Charles Price ;   et al.
2011-02-17
Alpha 2 Delta Ligands for Fibromyalgia and Other Disorders
App 20090203782 - Dooley; David James ;   et al.
2009-08-13
Amino acids with affinity for the .alpha.2.delta.-protein
Grant 7,517,909 - Thorpe , et al. April 14, 2
2009-04-14
Prodrugs of amino acids with affinity for the .alpha.2.delta.-protein
Grant 7,491,835 - Donevan , et al. February 17, 2
2009-02-17
Method of treatment for sexual dysfunction
Grant 7,432,299 - Taylor, Jr. , et al. October 7, 2
2008-10-07
Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders
App 20080207755 - Dooley; David James ;   et al.
2008-08-28
Alpha 2 delta ligands for post-traumatic stress disorder
Grant 7,381,747 - Dooley , et al. June 3, 2
2008-06-03
Pharmaceutical Uses For Alpha2delta Ligands
App 20070293570 - Dooley; David James ;   et al.
2007-12-20
Pharmaceutical Uses For Alpha2delta Ligands
App 20070276039 - Dooley; David James ;   et al.
2007-11-29
Alpha2delta ligands for the treatment of fibromyalgia and other disorders
App 20070238749 - Taylor; Charles Price JR. ;   et al.
2007-10-11
Pharmaceutical Uses For Alpha2delta Ligands
App 20070213401 - Dooley; David James ;   et al.
2007-09-13
Tetrazole and oxadiazolone substituted .beta.-amino acid derivatives
Grant 7,250,433 - Barta , et al. July 31, 2
2007-07-31
Pharmaceutical Uses For Alpha2delta Ligands
App 20070161706 - Dooley; David James ;   et al.
2007-07-12
Pharmaceutical Uses For Alpha2delta Ligands
App 20070161707 - Dooley; David James ;   et al.
2007-07-12
Method of treating noninflammatory cartilage damage
Grant 7,189,747 - Schrier , et al. March 13, 2
2007-03-13
Alpha 2 Delta Ligands For Fibromyalgia And Other Disorders
App 20070027212 - Dooley; David James ;   et al.
2007-02-01
Alpha2delta ligands for fibromyalgia and other disorders
Grant 7,164,034 - Dooley , et al. January 16, 2
2007-01-16
Method of treating tinnitus
Grant 7,138,542 - Dooley , et al. November 21, 2
2006-11-21
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
Grant 7,122,678 - Bryans , et al. October 17, 2
2006-10-17
Amino acids with affinity for the alpha-2-delta-protein
App 20060154972 - Barta; Nancy Sue ;   et al.
2006-07-13
Amino acids with affinity for the .alpha.-2-delta-protein
Grant 7,064,147 - Barta , et al. June 20, 2
2006-06-20
Method of treating tinnitus
App 20060100281 - Dooley; David James ;   et al.
2006-05-11
Cycloproply .beta.-amino acid derivatives
Grant 7,030,267 - Schwarz , et al. April 18, 2
2006-04-18
Method of treating tinnitus
Grant 7,026,505 - Dooley , et al. April 11, 2
2006-04-11
Amino acids with affinity for the alpha2delta-protein
App 20050272783 - Barta, Nancy Sue ;   et al.
2005-12-08
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
Grant 6,921,835 - Bryans , et al. July 26, 2
2005-07-26
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
App 20050159487 - Bryans, Justin Stephen ;   et al.
2005-07-21
Prodrugs of amino acids with affinity for the alpha2delta-protein
App 20050070483 - Donevan, Sean D. ;   et al.
2005-03-31
Tetrazole and oxadiazolone substituted beta-amino acid derivatives
App 20050014804 - Barta, Nancy Sue ;   et al.
2005-01-20
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
App 20050014841 - Hu, Lain-Yen ;   et al.
2005-01-20
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
App 20050004167 - Bora, Keenan Martin ;   et al.
2005-01-06
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
Grant 6,809,119 - Hu , et al. October 26, 2
2004-10-26
Alpha2delta ligands for fibromyalgia and other disorders
App 20040186177 - Dooley, David James ;   et al.
2004-09-23
Method of treatment
App 20040180958 - Taylor, Charles Price JR. ;   et al.
2004-09-16
Gabapentin analogues for fibromy algia and concomitant disorders
App 20040180959 - Dooley, David James ;   et al.
2004-09-16
Method of treatment for sexual dysfunction
App 20040176456 - Taylor, Charles Price JR. ;   et al.
2004-09-09
Cyclopropyl beta-amino acid derivatives
App 20040147608 - Schwarz, Jacob Bradley ;   et al.
2004-07-29
Therapeutic use of alpha-2-delta ligands
App 20040143014 - Bertrand, Claude Philippe ;   et al.
2004-07-22
Alpha2delta ligands for the treatment of fibromyalgia and other disorders
App 20040138305 - Taylor, Charles Price JR. ;   et al.
2004-07-15
Pharmaceutical uses for alpha2delta ligands
App 20040132636 - Dooley, David James ;   et al.
2004-07-08
Method of treating cartilage damage
App 20040097405 - Schrier, Denis ;   et al.
2004-05-20
Mono-and disubstituted 3-propyl gamma-aminobutyric acids
App 20040063789 - Belliotti, Thomas Richard ;   et al.
2004-04-01
Novel amines as pharmaceutical agents
App 20030229054 - Belliotti, Thomas Richard ;   et al.
2003-12-11
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
App 20030220397 - Bryans, Justin Stephen ;   et al.
2003-11-27
Mono-and disubstituted 3-propyl gamma-aminobutyric acids
Grant 6,642,398 - Belliotti , et al. November 4, 2
2003-11-04
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
Grant 6,635,673 - Bryans , et al. October 21, 2
2003-10-21
Amino acids with affinity for the alpha-2-delta-protein
App 20030195251 - Barta, Nancy Sue ;   et al.
2003-10-16
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
Grant 6,632,831 - Hays , et al. October 14, 2
2003-10-14
Gamma amino butyric and acid analogs
Grant 6,627,771 - Belliotti , et al. September 30, 2
2003-09-30
Mono-and disubstituted 3-propyl gamma-aminobutyric acids
App 20030181523 - Belliotti, Thomas Richard ;   et al.
2003-09-25
Method of treating tinnitus
App 20030176504 - Dooley, David James ;   et al.
2003-09-18
Method of treating noninflammatory cartilage damage
Grant 6,620,829 - Schrier , et al. September 16, 2
2003-09-16
Branched Chain Amino Acid-dependent Aminotransferase Inhibitors And Their Use In The Treatment Of Neurodegenerative Diseases
App 20030162779 - Hays, Sheryl Jeanne ;   et al.
2003-08-28
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
App 20030149110 - Hu, Lain-Yen ;   et al.
2003-08-07
4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
Grant 6,545,022 - Bryans , et al. April 8, 2
2003-04-08
1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
Grant 6,518,289 - Bryans , et al. February 11, 2
2003-02-11
Method of treating cartilage damage
App 20020072533 - Schrier, Denis ;   et al.
2002-06-13
Branched alkyl pyrrolidine-3-carboxylic acids
Grant 6,245,801 - Bryans , et al. June 12, 2
2001-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed